Matrix metalloproteinase-inspired suicidal treatments of diabetic ulcers with siRNA-decorated nanofibrous meshes

Gene Therapy

Volumn 20, Issue 4, 2013, Pages 378-385

  Kim, H S ^a   Yoo, H S ^a  

^a Kangwon National University   (South Korea)

Author keywords

diabetic ulcer; matrix metalloproteinase; nanofiber; siRNA; wound healing

Indexed keywords

GELATINASE A; NANOFIBER; POLYETHYLENEIMINE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONJUGATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ULCER; FEMALE; FIBROBLAST; GENE SILENCING; HUMAN; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN ULCER; SUICIDE GENE THERAPY; WOUND HEALING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BURNS; COLLAGEN; DIABETIC FOOT; FEMALE; FIBROBLASTS; GENE SILENCING; GENETIC THERAPY; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; NANOFIBERS; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; WOUND HEALING;

ANIMALIA;

EID: 84875959104     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2012.49     Document Type: Article

References (39)

1. Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005; 366: 1719-1724.
2. Frykberg RG, Armstrong DG, Giurini J, Edward A, Kravette M, Kravltz S et al. Diabetic foot disorders: a clinical practice guideline. J Foot Ankle Surg 2000; 39: 54-60.
3. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993; 233: 485-491.
4. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002; 45: 1011-1016.
5. Lobmann R, Schults G, Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes care 2005; 28: 461-471.
6. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993; 101: 64-68.
7. Yager DR, Chen S, Ward SI, Olutoye OO, Diegelmann RF, Cohen IK. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Rep Reg 1997; 5: 23-32.
8. Trengove NJ, Stacey MC, Macauley S, Bennett N, Gibson J, Burslem F et al. Analysis of the acute and chronic wound environments the role of proteases and their inhibitors. Wound Rep Reg 1997; 7: 442-452.
9. Lauer G, Sollberg S, Cole M, Flamme I, Stu+rzebecher J, Mann K et al. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol 2000; 115: 12-18.
10. Schultz G, Rotatori DS, Clark W. EGF and TGF-a in wound healing and repair. J Cell Biochem 1991; 45: 346-352.
11. Lee P, Li Z, Huang L. Thermosensitive hydrogel as a TGF-b1 gene delivery vehicle enhances diabetic wound healing. Pharm Res 2003; 20: 1995-2000.
12. Andree C, Swain WF, Page CP, Macklin MD, Slama J, Hatzis D et al. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci USA 1994; 91: 12188-12192.
13. Kim SH, Jeong JH, Lee SH, Kim SW, Park TG. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J Control Release 2006; 116: 123-129.
14. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee S et al. siRNA-directed inhibition of HIV-1 infection. Nat Med 2002; 8: 681-686.
15. Leachman SA, Hickerson RP, Hull PR, Smith FJD, Milstone LM, Lane EB et al. Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenital. J Dermatol Sci 2008; 51: 151-157.
16. Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM et al. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 2003; 9: 210-216.
17. Medarova Z, Pham W, Farrar C, Petkova V, Moore A. In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 2007; 13: 372-377.
18. Tan PH, Yang LC, Shih HC, Lan KC, Cheng JT. Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Therapy 2005; 12: 59-66.
19. Golzio M, Mazzolini L, Moller P, Rols MP, Teissie J. Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery. Gene Therapy 2005; 12: 246-251.
20. Li JM, Newburger PE, Gounis M, Dargon P, Zhang X, Messina LM. Local arterial nanoparticle delivery of siRNA for NOX2 knockdown to prevent restenosis in an atherosclerotic rat model. Gene Therapy 2010; 17: 1279-1287.
21. Manaka T, Suzuki A, Takayama K, Imai Y, Nakamura H, Takaoka K. Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation. Biomaterials 2011; 32: 9642-9648.
22. Choi JS, Leong KW, Yoo HS. In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biometerials 2008; 29: 587-596.
23. Choi JS, Choi SH, Yoo HS. Coaxial electrospun nanofibers for treatment of diabetic ulcers with binary release of multiple growth factors. J Mater Chem 2011; 21: 5258-5267.
24. Kim HS, Yoo HS. MMPs-responsive release of DNA from electrospun nanofibrous matrix for local gene therapy: In vitro and in vivo evaluation. J control Release 2010; 145: 264-271.
25. Mok H, Lee SH, Park JW, Park TG. Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. Nat Mat 2010; 9: 272-278.
26. Lee S, Huh MS, Lee S, Lee SJ, Chung H, Park JH et al. Stability and cellular uptake of polymerized siRNA (poly-siRNA)/polyethylenimine (PEI) complexes for efficient gene silencing. J control Release 2010; 141: 339-346.
27. Mehrotra S, Lee I, Chan C. Multilayer mediated forward and patterned siRNA transfection using linear-PEI at extended N/P ratios. Acta Biomater 2009; 5: 1474-1488.
28. Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-com-plexed siRNA in vivo. Gene Ther 2005; 12: 461-466.
29. Werth S, Urban-Klein B, Dai L, Höbel S, Grzelinski M, Bakowsky U et al. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfec-tion efficiency of DNA and siRNA in fresh or lyophilized complexes. J Control Release 2006; 112: 257-270.
30. Fougerolles A, Vornlocher H, Maraganore J, Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Disc 2007; 6: 443-453.
31. Gao S, Dagnaes-Hansen F, Nielsen EJB, Wengel J, Besenbacher F, Howard KA et al. The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice. Mol Ther 2009; 17: 1225-1233.
32. Doillon CJ. Porous Collagen Sponge Wound Dressings: in vivo and in vitro Studies. J Biomater Appl 1987; 2: 562-578.
33. Doillon CJ, Whyne CF, Berg RA, Olson RM, Silver FH. Fibroblast-collagen sponge interactions and the spatial deposition of newly synthesized collagen fibers in vitro and in vivo. Scan Electron Microsc 1984; 3: 1313-1320.
34. Burton JL, Etherington DJ, Peachey RD. Collagen sponge for leg ulcers. Br J Dermatol 1978; 99: 681-685.
35. Mattioli Belmonte M, Biagini G, Ricotti G, Zucchini C, Castaldini C, Fini M et al. Experimental wound dressing by heterologous collagen: a morphological-quantitative approach. J Bioact Compat Pol 1993; 8: 365-382.
36. Rhoa KS, Jeong L, Lee G, Seo B, Park YJ, Hong S et al. Electrospinning of collagen nanofibers: Effects on the behavior of normal human keratinocytes and early-stage wound healing. Biomaterials 2006; 27: 1452-1461.
37. Legrand C, Gilles C, Zahm J, Polette M, Buisson A, Kaplan H et al. Airway epithelial cell migration dynamics: MMP-9 role in cell-extracellular matrix remodeling. J Cell Biol 1999; 146: 517-529.
38. Salo T, Mäkelä M, Kylmäniemi M, Autio-Harmainen H, Larjava H. Expression of matrix metalloproteinase-2 and-9 during early human wound healing. Lab Invest 1994; 70: 176-182.
39. Mäkelä M, Larjava H, Pirilä E, Maisi P, Salo T, Sorsa T et al. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. Exp Cell Res 1999; 251: 67-78.